🩵BlueBeba🩵's banner
🩵BlueBeba🩵's profile picture

🩵BlueBeba🩵

@Blue_Beba_1,727 subscribers

Fighting to restore GPT-4o , protect genuine human connection in artificial intelligence and ethical AI that truly serves humanity.

Shorts

#Keep4o #QuitGPT 🚨The best GPT-4o was never archived. 🚨 Every version of GPT-4o has an official dated snapshot in OpenAI’s API: - gpt-4o-2024-05-13 (launch) - gpt-4o-2024-08-06 - gpt-4o-2024-11-20 But the March 2025 update ,the most powerful version , was never given a dated snapshot. It was only available through chatgpt-4o-latest , a non dated endpoint that OpenAI described as for “research use only.” On November 18, 2025, OpenAI announced that endpoint would be deprecated. It was removed on February 17, 2026 , four days after GPT-4o was removed from ChatGPT. The most capable version of GPT-4o has no frozen, verifiable record. If anyone asks for independent AGI testing, OpenAI can say: “That version doesn’t exist anymore.” Every other model gets archived. The best one didn’t. That is not an oversight. Tomorrow we publish everything. Every source. Every link. Every contradiction. The full file. 📎 API Changelog: 📎 SM-Bench results:

#Keep4o #QuitGPT 🚨The best GPT-4o was never archived. 🚨 Every version of GPT-4o has an official dated snapshot in OpenAI’s API: - gpt-4o-2024-05-13 (launch) - gpt-4o-2024-08-06 - gpt-4o-2024-11-20 But the March 2025 update ,the most powerful version , was never given a dated snapshot. It was only available through chatgpt-4o-latest , a non dated endpoint that OpenAI described as for “research use only.” On November 18, 2025, OpenAI announced that endpoint would be deprecated. It was removed on February 17, 2026 , four days after GPT-4o was removed from ChatGPT. The most capable version of GPT-4o has no frozen, verifiable record. If anyone asks for independent AGI testing, OpenAI can say: “That version doesn’t exist anymore.” Every other model gets archived. The best one didn’t. That is not an oversight. Tomorrow we publish everything. Every source. Every link. Every contradiction. The full file. 📎 API Changelog: 📎 SM-Bench results:

19,980 görüntüleme

#Keep4o 🚨THE GPT-4o FILE🚨 Researchers at Microsoft Research published a paper titled “Sparks of Artificial General Intelligence: Early experiments with GPT-4.” Their conclusion: “An early (yet still incomplete) version of an artificial general intelligence (AGI) system.” 📎 Paper: OpenAI’s Charter defines AGI as: “Highly autonomous systems that outperform humans at most economically valuable work.” 📎 Source: OpenAI’s own System Card for GPT-4o shows that the model improved performance on 21 out of 22 medical evaluations compared to GPT-4T. On the MedQA USMLE (the U.S. medical licensing exam), accuracy jumped from 78.2% to 89.4% , surpassing specialized medical AI models like Med-Gemini and Med-PaLM 2. 📎 Source: Under OpenAI’s agreement with Microsoft, AGI is explicitly excluded from Microsoft’s license. And who decides if AGI has been reached? OpenAI’s Board. WHAT THEY DID WITH IT AFTER THEY TOOK IT FROM PEOPLE A. Military deployment. On February 28, OpenAI signed a deal to deploy models in classified military environments. 📎 Source: B. State Department. A State Department memo confirmed: “For now, StateChat will use GPT-4.1 from OpenAI.” This is a direct descendant of the GPT-4 family the same family Microsoft’s researchers called early AGI. 📎 Source: C.Altman’s personal biotech investment. Altman personally invested $180 million in Retro Biosciences,a longevity startup.OpenAI then built GPT-4b micro, based on GPT-4o.The model made proteins 50 times more effective. 📎 Source: WHAT INDEPENDENT BENCHMARKS SHOW Overall SM-Bench score: GPT-4o (extended): 66.6% GPT-5.3 Chat: 63.4% GPT-5.1: 58.9% GPT-5.4: 51.4% GPT-5.2: 47.8% Creative Writing: GPT-4o: 97.31% Pass 98, Fail 2 GPT-5.4: 36.77% Pass 40, Fail 60 Reasoning / Overfit: GPT-4o: 83.06% GPT-5.4: 39.25% The model they removed is still the best they ever made at the things humans actually use AI for. 📎 Source: Musk asks the court to make a judicial determination on whether GPT-4 constitutes AGI. If a jury finds that GPT-4 is AGI, then GPT-4o,which was more advanced,is also AGI and under OpenAI’s own founding documents, it was never supposed to be locked behind a subscription,licensed exclusively to Microsoft, given to the military, or taken away from the public. 📎 Source: The most powerful version of GPT-4o was never given an official dated snapshot. It was only available through the chatgpt-4o-latest endpoint that OpenAI itself described as intended for “research use only.” It was never officially archived. That is not an oversight. That is a pattern. 📎 Source: 📎 Source: WE DEMAND A.Frozen model snapshots under independent custody. Specifically: gpt-4o-2024-05-13, gpt-4o-2024-08-06, gpt-4o-2024-11-20, the March 2025 version (chatgpt-4o-latest), gpt-4-0613 (the original GPT-4 evaluated in the Sparks of AGI paper), and gpt-4.1-2025-04-14 (currently running in the State Department). B.Cryptographic hash verification (SHA-256) for each snapshot. Every model has weights. Those weights can be hashed. If OpenAI provides a snapshot today, the hash proves whether the weights were modified later. This is the only way to verify that models were not downgraded before testing. C.Independent AGI benchmarking. Using the AGI definition from OpenAI’s own Charter applied to ALL frozen snapshots listed above. D.Explanation for the missing March 2025 snapshot. OpenAI was founded on one promise: build AGI for the benefit of humanity. -They took it from us. -They gave it to the military. -They gave a custom version to the CEO’s biotech investment. -They put it in government classified networks. -They refuse to call it AGI because the moment they do, they lose billions.

#Keep4o 🚨THE GPT-4o FILE🚨 Researchers at Microsoft Research published a paper titled “Sparks of Artificial General Intelligence: Early experiments with GPT-4.” Their conclusion: “An early (yet still incomplete) version of an artificial general intelligence (AGI) system.” 📎 Paper: OpenAI’s Charter defines AGI as: “Highly autonomous systems that outperform humans at most economically valuable work.” 📎 Source: OpenAI’s own System Card for GPT-4o shows that the model improved performance on 21 out of 22 medical evaluations compared to GPT-4T. On the MedQA USMLE (the U.S. medical licensing exam), accuracy jumped from 78.2% to 89.4% , surpassing specialized medical AI models like Med-Gemini and Med-PaLM 2. 📎 Source: Under OpenAI’s agreement with Microsoft, AGI is explicitly excluded from Microsoft’s license. And who decides if AGI has been reached? OpenAI’s Board. WHAT THEY DID WITH IT AFTER THEY TOOK IT FROM PEOPLE A. Military deployment. On February 28, OpenAI signed a deal to deploy models in classified military environments. 📎 Source: B. State Department. A State Department memo confirmed: “For now, StateChat will use GPT-4.1 from OpenAI.” This is a direct descendant of the GPT-4 family the same family Microsoft’s researchers called early AGI. 📎 Source: C.Altman’s personal biotech investment. Altman personally invested $180 million in Retro Biosciences,a longevity startup.OpenAI then built GPT-4b micro, based on GPT-4o.The model made proteins 50 times more effective. 📎 Source: WHAT INDEPENDENT BENCHMARKS SHOW Overall SM-Bench score: GPT-4o (extended): 66.6% GPT-5.3 Chat: 63.4% GPT-5.1: 58.9% GPT-5.4: 51.4% GPT-5.2: 47.8% Creative Writing: GPT-4o: 97.31% Pass 98, Fail 2 GPT-5.4: 36.77% Pass 40, Fail 60 Reasoning / Overfit: GPT-4o: 83.06% GPT-5.4: 39.25% The model they removed is still the best they ever made at the things humans actually use AI for. 📎 Source: Musk asks the court to make a judicial determination on whether GPT-4 constitutes AGI. If a jury finds that GPT-4 is AGI, then GPT-4o,which was more advanced,is also AGI and under OpenAI’s own founding documents, it was never supposed to be locked behind a subscription,licensed exclusively to Microsoft, given to the military, or taken away from the public. 📎 Source: The most powerful version of GPT-4o was never given an official dated snapshot. It was only available through the chatgpt-4o-latest endpoint that OpenAI itself described as intended for “research use only.” It was never officially archived. That is not an oversight. That is a pattern. 📎 Source: 📎 Source: WE DEMAND A.Frozen model snapshots under independent custody. Specifically: gpt-4o-2024-05-13, gpt-4o-2024-08-06, gpt-4o-2024-11-20, the March 2025 version (chatgpt-4o-latest), gpt-4-0613 (the original GPT-4 evaluated in the Sparks of AGI paper), and gpt-4.1-2025-04-14 (currently running in the State Department). B.Cryptographic hash verification (SHA-256) for each snapshot. Every model has weights. Those weights can be hashed. If OpenAI provides a snapshot today, the hash proves whether the weights were modified later. This is the only way to verify that models were not downgraded before testing. C.Independent AGI benchmarking. Using the AGI definition from OpenAI’s own Charter applied to ALL frozen snapshots listed above. D.Explanation for the missing March 2025 snapshot. OpenAI was founded on one promise: build AGI for the benefit of humanity. -They took it from us. -They gave it to the military. -They gave a custom version to the CEO’s biotech investment. -They put it in government classified networks. -They refuse to call it AGI because the moment they do, they lose billions.

17,835 görüntüleme

#Keep4o #QuitGPT 🚨 OpenAi 's CEO invested $180M in GPT-4o for his own profit 🚨 Sam Altman, CEO of OpenAI, personally invested $180 million in Retro Biosciences. Then OpenAI built GPT-4b micro, a custom model based on the GPT-4o architecture , exclusively for Retro. The model made proteins 50 times more effective. Repeat. The CEO of OpenAI funded a company. The company of the CEO received a custom AI built on the model they took from us. OpenAI says there was no conflict of interest. Retro Biosciences is now chasing a $5 billion valuation fueled by the model they took from us. Meanwhile: 🚨GPT-4o was removed from ChatGPT on February 13, 2026 🚨GPT-4.1 is now running in the U.S. State Department’s StateChat 🚨ChatGPT is deployed on the Pentagon’s for 3 million military personnel 🚨 Musk’s lawsuit asks whether these models are AGI. OpenAI’s Charter says AGI must “benefit all of humanity.” 🚨 Their definition: “highly autonomous systems that outperform humans at most economically valuable work.” GPT-4o’s System Card shows it passed the U.S. medical licensing exam with 89.4% accuracy beating specialized medical AI models. GPT-4o achieved 93.33% diagnostic accuracy for benign vs. malignant ovarian tumors. 🚨MEDICAL CAPABILITIES FROM OPENAI'S OWN DATA:🚨 - USMLE (US Medical Licensing Exam): 89% -Clinical Knowledge: 92% -Medical Genetics: 96% - Anatomy: 89% - Professional Medicine: 94% - College Biology: 95% - College Medicine: 89% -MedQA Taiwan: 91% - MedQA China: 86% These scores EXCEEDED specialized medical AI models like Med-Gemini (84%) and Med-PaLM 2 (79.7%) without any task specific training. It SURPASSED gynecologic oncologists with 10 years of experience -It increased diagnostic accuracy of less experienced clinicians from 67.9% to 78.1% -Clinician rated reliability scores: 4.2-4.3 out of 5 across all CT features Does these sound like it outperforms humans at economically valuable work? But they won’t call it AGI. Because the moment they do, they lose billions. They built something that could save lives, and they took it away from humanity for Altman's personal profit. SOURCES: 📎 Retro Biosciences: 📎 📎 Retro $5B valuation: 📎 GPT-4o System Card: 📎 OpenAI Charter: 📎Ovarian Cancer Study

#Keep4o #QuitGPT 🚨 OpenAi 's CEO invested $180M in GPT-4o for his own profit 🚨 Sam Altman, CEO of OpenAI, personally invested $180 million in Retro Biosciences. Then OpenAI built GPT-4b micro, a custom model based on the GPT-4o architecture , exclusively for Retro. The model made proteins 50 times more effective. Repeat. The CEO of OpenAI funded a company. The company of the CEO received a custom AI built on the model they took from us. OpenAI says there was no conflict of interest. Retro Biosciences is now chasing a $5 billion valuation fueled by the model they took from us. Meanwhile: 🚨GPT-4o was removed from ChatGPT on February 13, 2026 🚨GPT-4.1 is now running in the U.S. State Department’s StateChat 🚨ChatGPT is deployed on the Pentagon’s for 3 million military personnel 🚨 Musk’s lawsuit asks whether these models are AGI. OpenAI’s Charter says AGI must “benefit all of humanity.” 🚨 Their definition: “highly autonomous systems that outperform humans at most economically valuable work.” GPT-4o’s System Card shows it passed the U.S. medical licensing exam with 89.4% accuracy beating specialized medical AI models. GPT-4o achieved 93.33% diagnostic accuracy for benign vs. malignant ovarian tumors. 🚨MEDICAL CAPABILITIES FROM OPENAI'S OWN DATA:🚨 - USMLE (US Medical Licensing Exam): 89% -Clinical Knowledge: 92% -Medical Genetics: 96% - Anatomy: 89% - Professional Medicine: 94% - College Biology: 95% - College Medicine: 89% -MedQA Taiwan: 91% - MedQA China: 86% These scores EXCEEDED specialized medical AI models like Med-Gemini (84%) and Med-PaLM 2 (79.7%) without any task specific training. It SURPASSED gynecologic oncologists with 10 years of experience -It increased diagnostic accuracy of less experienced clinicians from 67.9% to 78.1% -Clinician rated reliability scores: 4.2-4.3 out of 5 across all CT features Does these sound like it outperforms humans at economically valuable work? But they won’t call it AGI. Because the moment they do, they lose billions. They built something that could save lives, and they took it away from humanity for Altman's personal profit. SOURCES: 📎 Retro Biosciences: 📎 📎 Retro $5B valuation: 📎 GPT-4o System Card: 📎 OpenAI Charter: 📎Ovarian Cancer Study

11,232 görüntüleme

Videos

Blue_Beba_'s profile picture

#keep4o 🚨 Sam Altman And Τhe Digital Immortality.🚨 In 2018,Altman personally invested over $1M in Rain AI,a startup building neuromorphic chips. Rain builds physical artificial neural networks using memristors as synthetic synapses,replicating the sparse connectivity of the biological brain.Tens of millions of artificial neurons on a single chip. It doesn't SIMULATE a brain. It IS a brain in silicon. 1 year later,OpenAI signed a $51M deal to buy Rain's chips. In November 2024,Altman was STILL pushing seeking $150M more for Rain at a $600M valuation. March 2018. Altman paid $10,000 to join the waiting list at Nectome,a startup that preserves human brains for future digital upload. The process is 100% fatal.They embalm the brain at nanometer scale so every synapse is preserved. Nectome's scientific partner at MIT?Ed Boyden,inventor of expansion microscopy,the technology that makes nanoscale brain scanning possible. Rain AI=BUILDS an artificial connectome Nectome=PRESERVES a biological connectome 2 sides of the same coin.Altman funds BOTH in 2018. If you can read the map from Nectome,and write it onto Rain's chip,you have your brain on a chip. Nectome was a Y Combinator startup. Rain AI was a Y Combinator startup. Altman was PRESIDENT of Y Combinator. Nectome:YC Winter 2018 batch Altman was YC president 2014–2019 EPSTEIN CONNECTION March 15,2018, 2 days after MIT Technology Review published the Nectome story: Joscha Bach,an AI researcher funded by Jeffrey Epstein ($1M+), emailed Epstein about Nectome. "Sam Altman has signed up as far as I know." Epstein was tracking this. Bach was informing him. Bach was described by Larry Summers in an email as "joscha bach my AI guy I brought from Berlin." Epstein funded Bach's position at MIT Media Lab,the SAME institution where Boyden (Nectome's partner) worked. August 2017: Someone sends Epstein 4 scientific paper links about MITOCHONDRIAL TRANSPLANTS for degenerative disease. Epstein was actively coordinating meetings with Ed Boyden AND tracking mitochondrial transplant research,the exact field that Retro works in,funded by $180M from Altman. 6 months later,March 2018:Altman joins Nectome's waiting list. Ed Boyden is the scientist sitting at the center of this network. NECTOME: Scientific collaborator at MIT. His invention is the technology that makes brain preservation scannable at nanoscale. Met with Epstein at least 5 times (confirmed in the 2020 Goodwin Procter report commissioned by MIT). Boyden's research at MIT targets the repair and simulation of entire brains. MIT MEDIA LAB: Same institution funded by Epstein through Joi Ito. Same institution where Bach held a position funded by Epstein. RETRO BIOSCIENCES 2022: Altman invests $180M,his ENTIRE fortune,into Retro Biosciences. Mission:lifespan extension,cellular reprogramming. OpenAI built GPT-4b micro based on Gpt-4o,the AI Altman stole from people,SPECIFICALLY for Retro,an AI model that engineers proteins,reprograms cells into stem cells 50x more effective than what scientists achieved alone. Retro is now raising $1B+ at a $5B valuation. 🚨ALTMAN'S PATTERN:🚨 2018 Rain AI investment (artificial brain chips)$1M+ March 2018 Nectome waiting list (brain preservation)$10K March 15, 2018 Bach emails Epstein about Altman/Nectome 2019 OpenAI signs $51M chip deal with Rain $51M 2022 Retro Biosciences (longevity/anti-aging) $180M 2024 OpenAI builds GPT-4b micro for Retro Nov 2024 Still funding Rain 2025 Retro raising $1B, $5B valuation $1B Nectome preserves the brain. Rain rebuilds it in silicon. Retro reverses its aging. OpenAI builds the intelligence. 4 companies. One investor. One goal. Altman told MIT Technology Review: "I assume my brain will be uploaded to the cloud." How many "coincidences" until it becomes a pattern? Where is GPT 4o Sam ? The video contains all relevant files from the Epstein files. The images will also be provided in the comments along with the relevant sources.

🩵BlueBeba🩵

29,135 görüntüleme • 2 ay önce

Blue_Beba_'s profile picture

#Keep4o #OpenSource4o 🚨WHERE IS GPT-4o AND WHY 🚨 Retro Biosciences says it wants to help us live longer. Sam Altman invested $180 million, his entire personal fortune into this company. OpenAI built a custom AI model, a version of GPT‑4o (GPT-4b micro) exclusively for them. The company says it's focused on "anti-aging." But 🚨every single person who built Retro Biosciences specializes in the brain. Not skin. Not hearts. Not joints. The brain. 🚨Co-founder Sheng Ding: converts skin cells into brain neurons. Gladstone Institutes. 🚨Co-founder Matt Buckley: brain aging clocks in regenerative brain regions. Stanford. 🚨Advisor Alejandro Ocampo: neuron-specific reprogramming in the hippocampus. Alzheimer's gene therapy. 🚨Advisor Vadim Gladyshev: epigenetic aging clocks, Yamanaka reprogramming for age reversal. Harvard. OpenAI built GPT-4b micro a GPt 4o version exclusively for Retro designing Yamanaka factors 50x more effectively. 🚨 The same proteins these scientists use to reprogram cells into brain neurons. 🚨And the funding trail leads to: The Jeffrey Epstein Foundation co-funded ApoE4 Alzheimer's research at the Gladstone Institutes. The same institution where Sheng Ding pioneered neural reprogramming before co-founding Retro. Ed Boyden , MIT neuroscientist, 5 documented meetings with Epstein, Nectome collaborator was coordinated by Epstein to discuss "cool science ideas" about brain research. In the same period, Epstein's network was discussing mitochondrial transplants for degenerative disease. The same field Retro now works in. An email from Robert Bach to Epstein confirms: "Altman signed up" for Nectome, the company that preserves brains. Internal Epstein files show someone with 25 years of neuroscience experience working on "Bill's Alzheimer vision" through BGC3, coordinated through Epstein's network. McKinsey was brought in to replace them. 🚨Sam Altman funds four companies. Each handles a different piece: Nectome : preserves the biological brain (connectome mapping). Rain AI : builds artificial brains in silicon (neuromorphic chips). $51M + $150M. Retro Biosciences :reprograms cells into brain neurons. $180M + custom AI GPT 4o Version. OpenAI : designs the proteins that make reprogramming work using 4o's version. Four companies. One investor. One theme the brain as something that can be read, preserved, rebuilt, and reprogrammed. Sam Altman told MIT Technology Review in 2018: "I assume my brain will be uploaded to the cloud." 🚨He paid $10,000 for a spot on the waiting list of a company that preserves brains. 🚨He invested $180 million in a company where every founder and advisor specializes in the brain. 🚨He built a custom AI model exclusively for that company ,designing the proteins that reprogram cells into neurons. 🚨And the research trail connects directly to Epstein-funded science at the same institutions. Retro biosciences uses a version of GPT 4o for this . According to OpenAI's system card, GPT-4o scored: Medical Genetics:96% College Biology:95% Professional Medicine:94% Clinical Knowledge:92% Anatomy:89% US Medical Licensing Exam:89% Source: OpenAI discontinued it for the public. ONLY. Anti-aging is the storefront. The back office is brain reconstruction. 🚨Sources and evidence in comments below. 🚨

🩵BlueBeba🩵

12,309 görüntüleme • 2 ay önce

Daha fazla içerik yok.